Your browser doesn't support javascript.
loading
Efficient Production of the PET Radionuclide 133La for Theranostic Purposes in Targeted Alpha Therapy Using the 134Ba(p,2n)133La Reaction.
Brühlmann, Santiago Andrés; Kreller, Martin; Pietzsch, Hans-Jürgen; Kopka, Klaus; Mamat, Constantin; Walther, Martin; Reissig, Falco.
Afiliación
  • Brühlmann SA; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany.
  • Kreller M; Technische Universität Dresden, Faculty of Chemistry and Food Chemistry, D-01062 Dresden, Germany.
  • Pietzsch HJ; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany.
  • Kopka K; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany.
  • Mamat C; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany.
  • Walther M; Technische Universität Dresden, Faculty of Chemistry and Food Chemistry, D-01062 Dresden, Germany.
  • Reissig F; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, D-01328 Dresden, Germany.
Pharmaceuticals (Basel) ; 15(10)2022 Sep 21.
Article en En | MEDLINE | ID: mdl-36297279

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania